Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

Reliability of a two-probe ultrasound imaging procedure to measure strain in the Achilles tendon.

Molyneux P, Ellis RF, Carroll M.

J Foot Ankle Res. 2019 Sep 18;12:49. doi: 10.1186/s13047-019-0358-6. eCollection 2019.

2.

Recurring circadian disruption alters circadian clock sensitivity to resetting.

Leise TL, Goldberg A, Michael J, Montoya G, Solow S, Molyneux P, Vetrivelan R, Harrington ME.

Eur J Neurosci. 2018 Sep 30. doi: 10.1111/ejn.14179. [Epub ahead of print]

PMID:
30269396
3.

Swim drink study: a randomised controlled trial of during-exercise rehydration and swimming performance.

Briars GL, Gordon GS, Lawrence A, Turner A, Perry S, Pillbrow D, Walston FE, Molyneux P.

BMJ Paediatr Open. 2017 Oct 25;1(1):e000075. doi: 10.1136/bmjpo-2017-000075. eCollection 2017.

4.

Alterations in glutamatergic signaling contribute to the decline of circadian photoentrainment in aged mice.

Biello SM, Bonsall DR, Atkinson LA, Molyneux PC, Harrington ME, Lall GS.

Neurobiol Aging. 2018 Jun;66:75-84. doi: 10.1016/j.neurobiolaging.2018.02.013. Epub 2018 Feb 20.

5.

The relationship between perceived organisational threat and compassion for others: Implications for the NHS.

Henshall LE, Alexander T, Molyneux P, Gardiner E, McLellan A.

Clin Psychol Psychother. 2018 Mar;25(2):231-249. doi: 10.1002/cpp.2157. Epub 2017 Nov 23.

PMID:
29168607
6.

Ultrasound characteristics of the mid-portion of the Achilles tendon in runners: a systematic review protocol.

Molyneux P, Carroll M, Stewart S, Brenton-Rule A, Rome K.

Syst Rev. 2017 May 30;6(1):108. doi: 10.1186/s13643-017-0501-z.

7.

The Relationship Between Self-Blame for the Onset of a Chronic Physical Health Condition and Emotional Distress: A Systematic Literature Review.

Callebaut L, Molyneux P, Alexander T.

Clin Psychol Psychother. 2017 Jul;24(4):965-986. doi: 10.1002/cpp.2061. Epub 2016 Dec 7. Review.

PMID:
27925335
8.

Go back and predict the future.

Molyneux P.

Health Serv J. 2015 Nov 25;125(6469):40. No abstract available.

PMID:
26882730
9.

A Mouse Primary Hepatocyte Culture Model for Studies of Circadian Oscillation.

Molyneux PC, Pyle LA, Dillon M, Harrington ME.

Curr Protoc Mouse Biol. 2015 Dec 2;5(4):311-329. doi: 10.1002/9780470942390.mo150101.

PMID:
26629774
10.

Stratification and monitoring of natalizumab-associated progressive multifocal leukoencephalopathy risk: recommendations from an expert group.

McGuigan C, Craner M, Guadagno J, Kapoor R, Mazibrada G, Molyneux P, Nicholas R, Palace J, Pearson OR, Rog D, Young CA.

J Neurol Neurosurg Psychiatry. 2016 Feb;87(2):117-25. doi: 10.1136/jnnp-2015-311100. Epub 2015 Oct 22. Review.

11.

Autofluorescence Signatures of Seven Pathogens: Preliminary in Vitro Investigations of a Potential Diagnostic for Acanthamoeba Keratitis.

Molyneux PM, Kilvington S, Wakefield MJ, Prydal JI, Bannister NP.

Cornea. 2015 Dec;34(12):1588-92. doi: 10.1097/ICO.0000000000000645.

PMID:
26488626
12.

Suppression of Locomotor Activity in Female C57Bl/6J Mice Treated with Interleukin-1β: Investigating a Method for the Study of Fatigue in Laboratory Animals.

Bonsall DR, Kim H, Tocci C, Ndiaye A, Petronzio A, McKay-Corkum G, Molyneux PC, Scammell TE, Harrington ME.

PLoS One. 2015 Oct 15;10(10):e0140678. doi: 10.1371/journal.pone.0140678. eCollection 2015.

13.

A pragmatic approach to dealing with fingolimod-related lymphopaenia in Europe.

Giovannoni G, de Jong B, Derfuss T, Izquierdo G, Mazibrada G, Molyneux P, Nicholas R, Overell J, Ziemssen T, Juliusson G.

Mult Scler Relat Disord. 2015 Jan;4(1):83-4. doi: 10.1016/j.msard.2014.09.215. Epub 2014 Oct 13. No abstract available.

PMID:
25787058
14.

Spectroscopic measurements in scleritis: bluish-red or deep red?

Bannister NP, Wakefield MJ, Tatham A, Bugby SL, Molyneux PM, Prydal JI.

Br J Ophthalmol. 2014 Dec;98(12):1761-4. doi: 10.1136/bjophthalmol-2013-304086. Epub 2014 May 2.

PMID:
24795332
15.

Circadian rhythms of Per2::Luc in individual primary mouse hepatocytes and cultures.

Guenthner CJ, Luitje ME, Pyle LA, Molyneux PC, Yu JK, Li AS, Leise TL, Harrington ME.

PLoS One. 2014 Feb 3;9(2):e87573. doi: 10.1371/journal.pone.0087573. eCollection 2014.

16.

Voluntary exercise can strengthen the circadian system in aged mice.

Leise TL, Harrington ME, Molyneux PC, Song I, Queenan H, Zimmerman E, Lall GS, Biello SM.

Age (Dordr). 2013 Dec;35(6):2137-52. doi: 10.1007/s11357-012-9502-y. Epub 2013 Jan 23.

17.

Restricted wheel access following a light cycle inversion slows re-entrainment without internal desynchrony as measured in Per2Luc mice.

Castillo C, Molyneux P, Carlson R, Harrington ME.

Neuroscience. 2011 May 19;182:169-76. doi: 10.1016/j.neuroscience.2011.02.003. Epub 2011 Mar 12.

PMID:
21392557
18.

An evolving case of headaches and strokes.

Shah AJ, Breen DP, Thomas D, Cross J, Coles A, Molyneux P.

Pract Neurol. 2011 Apr;11(2):113-7. doi: 10.1136/jnnp.2011.242206. No abstract available.

PMID:
21385971
19.
20.

Hanging leg syndrome following traumatic nerve injury.

Breen DP, Thomas D, Shah AJ, Bukhari TI, Molyneux P.

J Neurol. 2010 Dec;257(12):2109-11. doi: 10.1007/s00415-010-5670-9. Epub 2010 Jul 24. No abstract available.

PMID:
20658247
21.

Migraine, an open and shut case?

Molyneux PD, Jordan K.

Pract Neurol. 2010 Jun;10(3):172-5. doi: 10.1136/jnnp.2010.212704. No abstract available.

PMID:
20498194
22.

Limbic encephalitis associated with antibodies to the NMDA receptor in Hodgkin lymphoma.

Zandi MS, Irani SR, Follows G, Moody AM, Molyneux P, Vincent A.

Neurology. 2009 Dec 8;73(23):2039-40. doi: 10.1212/WNL.0b013e3181c55e9b. No abstract available.

PMID:
19996080
23.

Decoding neuronal ensembles in the human hippocampus.

Hassabis D, Chu C, Rees G, Weiskopf N, Molyneux PD, Maguire EA.

Curr Biol. 2009 Apr 14;19(7):546-54. doi: 10.1016/j.cub.2009.02.033. Epub 2009 Mar 12.

24.

Visualizing jet lag in the mouse suprachiasmatic nucleus and peripheral circadian timing system.

Davidson AJ, Castanon-Cervantes O, Leise TL, Molyneux PC, Harrington ME.

Eur J Neurosci. 2009 Jan;29(1):171-80. doi: 10.1111/j.1460-9568.2008.06534.x. Epub 2008 Nov 21.

PMID:
19032592
25.

Sample sizes for brain atrophy outcomes in trials for secondary progressive multiple sclerosis.

Altmann DR, Jasperse B, Barkhof F, Beckmann K, Filippi M, Kappos LD, Molyneux P, Polman CH, Pozzilli C, Thompson AJ, Wagner K, Yousry TA, Miller DH.

Neurology. 2009 Feb 17;72(7):595-601. doi: 10.1212/01.wnl.0000335765.55346.fc. Epub 2008 Nov 12.

26.

Circadian entrainment aftereffects in suprachiasmatic nuclei and peripheral tissues in vitro.

Molyneux PC, Dahlgren MK, Harrington ME.

Brain Res. 2008 Sep 4;1228:127-34. doi: 10.1016/j.brainres.2008.05.091. Epub 2008 Jun 14.

PMID:
18598681
27.

Ghrelin effects on the circadian system of mice.

Yannielli PC, Molyneux PC, Harrington ME, Golombek DA.

J Neurosci. 2007 Mar 14;27(11):2890-5.

28.

c-Jun N-terminal kinase inhibitor SP600125 modulates the period of mammalian circadian rhythms.

Chansard M, Molyneux P, Nomura K, Harrington ME, Fukuhara C.

Neuroscience. 2007 Mar 30;145(3):812-23. Epub 2007 Jan 30.

29.

Behavioral and neurochemical sources of variability of circadian period and phase: studies of circadian rhythms of npy-/- mice.

Harrington M, Molyneux P, Soscia S, Prabakar C, McKinley-Brewer J, Lall G.

Am J Physiol Regul Integr Comp Physiol. 2007 Mar;292(3):R1306-14. Epub 2006 Nov 2.

30.

The world through tinted glasses.

Bennett DL, Webster GJ, Molyneux P, Descamps MJ, Plant GT, Pereira SP, Reilly MM.

Lancet. 2004 Jul 24-30;364(9431):388. No abstract available.

PMID:
15276402
31.

When London's found wanting.

Buxton N, Hebblewhite J, Kemp V, Molyneux P.

Health Serv J. 2003 May 15;113(5855):34-5. No abstract available.

PMID:
12774603
32.
33.

Clinical-MRI correlations in a European trial of interferon beta-1b in secondary progressive MS.

Molyneux PD, Barker GJ, Barkhof F, Beckmann K, Dahlke F, Filippi M, Ghazi M, Hahn D, MacManus D, Polman C, Pozzilli C, Kappos L, Thompson AJ, Wagner K, Yousry T, Miller DH; European Study Group on Interferon Beta-1b in Secondary Progressive MS.

Neurology. 2001 Dec 26;57(12):2191-7.

PMID:
11756596
34.

The effect of IFNbeta-1b on the evolution of enhancing lesions in secondary progressive MS.

Brex PA, Molyneux PD, Smiddy P, Barkhof F, Filippi M, Yousry TA, Hahn D, Rolland Y, Salonen O, Pozzilli C, Polman CH, Thompson AJ, Kappos L, Miller DH; European Study Group on Interferon beta-1b in Secondary Progressive MS.

Neurology. 2001 Dec 26;57(12):2185-90.

PMID:
11756595
35.

Sample size estimations for MRI-monitored trials of MS comparing new vs standard treatments.

Sormani MP, Rovaris M, Bagnato F, Molyneux P, Bruzzi P, Pozzilli C, Miller DH, Comi G, Filippi M.

Neurology. 2001 Nov 27;57(10):1883-5.

PMID:
11723280
36.

The effect of interferon beta-1b treatment on MRI measures of cerebral atrophy in secondary progressive multiple sclerosis. European Study Group on Interferon beta-1b in secondary progressive multiple sclerosis.

Molyneux PD, Kappos L, Polman C, Pozzilli C, Barkhof F, Filippi M, Yousry T, Hahn D, Wagner K, Ghazi M, Beckmann K, Dahlke F, Losseff N, Barker GJ, Thompson AJ, Miller DH.

Brain. 2000 Nov;123 ( Pt 11):2256-63.

PMID:
11050025
37.

Non-systemic vasculitic neuropathy presenting with a painful polyradiculopathy: a case report.

Molyneux PD, Barker R, Thomas PK, King RH, Miller DH.

J Neurol. 2000 Aug;247(8):645-6. No abstract available.

PMID:
11041335
38.

The precision of T1 hypointense lesion volume quantification in multiple sclerosis treatment trials: a multicenter study.

Molyneux PD, Brex PA, Fogg C, Lewis S, Middleditch C, Barkhof F, Sormani MP, Filippi M, Miller DH.

Mult Scler. 2000 Aug;6(4):237-40.

PMID:
10962544
39.

Lesion heterogeneity in multiple sclerosis: a study of the relations between appearances on T1 weighted images, T1 relaxation times, and metabolite concentrations.

Brex PA, Parker GJ, Leary SM, Molyneux PD, Barker GJ, Davie CA, Thompson AJ, Miller DH.

J Neurol Neurosurg Psychiatry. 2000 May;68(5):627-32.

40.

The use of magnetic resonance imaging in multiple sclerosis treatment trials: power calculations for annual lesion load measurement.

Molyneux PD, Miller DH, Filippi M, Yousry T, Kappos L, Gasperini C, Adèr HJ, Barkhof F.

J Neurol. 2000 Jan;247(1):34-40.

PMID:
10701895
41.
42.

Visual analysis of serial T2-weighted MRI in multiple sclerosis: intra- and interobserver reproducibility.

Molyneux PD, Miller DH, Filippi M, Yousry TA, Radü EW, Adèr HJ, Barkhof F.

Neuroradiology. 1999 Dec;41(12):882-8.

PMID:
10639661
44.

MRI enhancing lesion frequency from patients with MS enrolled in the placebo arms of clinical trials or in natural history studies.

Sormani MP, Molyneux PD, Barkhof F, Miller DH, Filippi M.

Magn Reson Imaging. 1999 Oct;17(8):1236-7. No abstract available.

PMID:
10499687
45.

Quantitative MRI in patients with secondary progressive MS treated with monoclonal antibody Campath 1H.

Paolillo A, Coles AJ, Molyneux PD, Gawne-Cain M, MacManus D, Barker GJ, Compston DA, Miller DH.

Neurology. 1999 Sep 11;53(4):751-7.

PMID:
10489036
46.

Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis.

Coles AJ, Wing MG, Molyneux P, Paolillo A, Davie CM, Hale G, Miller D, Waldmann H, Compston A.

Ann Neurol. 1999 Sep;46(3):296-304.

PMID:
10482259
47.

Proton MR spectroscopy in clinically isolated syndromes suggestive of multiple sclerosis.

Brex PA, Gomez-Anson B, Parker GJ, Molyneux PD, Miszkiel KA, Barker GJ, MacManus DG, Davie CA, Plant GT, Miller DH.

J Neurol Sci. 1999 Jun 15;166(1):16-22.

PMID:
10465494
48.
49.

Statistical power of MRI monitored trials in multiple sclerosis: new data and comparison with previous results.

Sormani MP, Molyneux PD, Gasperini C, Barkhof F, Yousry TA, Miller DH, Filippi M.

J Neurol Neurosurg Psychiatry. 1999 Apr;66(4):465-9.

50.

Evaluating clinical outcome and staff morale in a rehabilitation team for people with serious mental health problems.

Brooker C, Molyneux P, Deverill M, Repper J.

J Adv Nurs. 1999 Jan;29(1):44-51.

PMID:
10064281

Supplemental Content

Loading ...
Support Center